Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Corsair Pharma, Inc.

News headline image
Corsair Pharma Announces Three Presentations of Phase 1 Clinical Data for TRX-248 Transdermal System at the 2026 Pulmonary Hypertension Association Conference
From Corsair Pharma, Inc.
Via Business Wire
News headline image
Corsair Pharma Announces Positive Phase 1 Results for the TRX-248 Transdermal System in Pulmonary Arterial Hypertension
From Corsair Pharma, Inc.
Via Business Wire
News headline image
Corsair Pharma to Present New Data on Proprietary Treprostinil Prodrug Transdermal System at PHPN 2025 Symposium
From Corsair Pharma, Inc.
Via Business Wire
News headline image
Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System
From Corsair Pharma, Inc.
Via Business Wire
News headline image
Corsair Pharma Announces Appointment of George W. Mahaffey as Chief Executive Officer
From Corsair Pharma, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.